Lv4
620 积分 2021-07-27 加入
CAR-T therapy in solid tumors
13天前
已完结
Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate
1个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
2个月前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2个月前
已完结
Cytokine-engineered CAR T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukaemia
2个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
2个月前
已完结
CAR T cell immunotherapy for human cancer
2个月前
已完结
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
2个月前
已完结
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
2个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
3个月前
已完结
皖公网安备34019202002308
